KR910002845A - 크로만 유도체 - Google Patents

크로만 유도체 Download PDF

Info

Publication number
KR910002845A
KR910002845A KR1019900011156A KR900011156A KR910002845A KR 910002845 A KR910002845 A KR 910002845A KR 1019900011156 A KR1019900011156 A KR 1019900011156A KR 900011156 A KR900011156 A KR 900011156A KR 910002845 A KR910002845 A KR 910002845A
Authority
KR
South Korea
Prior art keywords
compound
formula
general formula
carbon atoms
chromen
Prior art date
Application number
KR1019900011156A
Other languages
English (en)
Inventor
랄프 게리케
맨프레트 바움가르드
잉게보르그 루에스
랄프 베르그만
페이어 쟈케스 드
Original Assignee
위르겐 호이만, 쉬틀러
메르크 파텐트 게젤샤프트 미트 베슈랭크터 하프퉁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 위르겐 호이만, 쉬틀러, 메르크 파텐트 게젤샤프트 미트 베슈랭크터 하프퉁 filed Critical 위르겐 호이만, 쉬틀러
Publication of KR910002845A publication Critical patent/KR910002845A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

내용 없음.

Description

크로만 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 일반식(I)의 크로만 유도체 및 그의 염
    상기식에서, R¹은 A이고, R²은 각각 H 또는 A이고, R¹과R²는 함께 탄소수 3내지 6의 알킬렌이고, R³는 CHO 또는 CH2OH이고, R4는 A, F, Cl, Br, I, OH, OA, OAC, SH, NO2, NH2, AcNH, COOH 및 또는 COOA로 일치환 또는 이치환 또는 비치환된 피리딜, 피리다진일, 피리미딘일, 피라진일, 옥소디히드로피리딜, 옥소디히드로피리다진일, 옥소디히드로피리미딘일, 옥소디히드로피라진일, 2-피롤리디논-1-일 또는 3-옥소시클로펜텐-1-일이고, R5와 R6은 각각 H, A, HO, CHO, ACO, ACS, HOOC, AOOC, AO-CS, ACOO, A-CS-O, 히드록시알킬, 머르캅토알킬, NO2, NH2, NHA, NA2, CN, F, Cl, Br, I, CF3, ASO, ASO2, AO-SO, AO-SO2, AcNH, AO-CO-NH, H2NSO, HANSO, A2NSO, HANSO2, A2NSO2, H2NCO, HANCO, A2NCO, H2NCS, HANCS, A2NCS, ASONH, ASO2NH, AOSONH, AOSO2NH, ACO-알킬, 니트로알킬, 시아노알킬, A-C(=NOH) A-C(=NNH2)이고 Z는 O, S, NH 또는 결합이고, A는 탄소수 1내지 6의 알킬이고, -알킬은 탄소수 1내지 6의 알킬렌이고, Ac는 탄소수 1내지 8의 알칸오일 또는 탄소수 7내지 11의 아로일이다.
  2. a)2,2-디메틸-3-포르밀-4-(1.2-디히드로-2-옥소-1-피리딜)-6-시아노-3-크로멘, b)2,2-디메틸-3-히드록시메틸-4-(1,2-히드로-2-옥소-1-피리딜)-6-시아노-3-크로멘, c)2,2-디메틸-3-프로밀-4-(6-옥소-1,6-디히드로-3-피리다진일옥시)-6-시아노-3-크로멘, 3.일반식(I)의 크로만 유도체를 제조하는 방법에 있어서, 일반식(Ⅱ)의 화합물을 일반식(Ⅲ)의 화합물과 반응시키거나,
    (상기식에서, E는 Cl, Br, I 또는 반응성 에스테르화 OH 그룹이고, R1, R2, R3, R4, R5, R6및 Z는 일반식(Ⅰ)에서 정의한 바와같다), 또는 R3가 CH2OH인 일반식(Ⅰ)의 화합물을 제조하기 위해서는, R3가 CHO인 일반식(Ⅰ)의 화합물을 환제로 처리하고/하거나, 일반식(Ⅰ)의 R4, R5및/또는 R6기로 전환시키고/시키거나, 일반식(Ⅰ)의 염기성 또는 산성 화합물을 산 또는 염기로 처리하여 그의 염으로 전환시킴을 특징으로 하는 방법.
  3. 내용 없음.
  4. 일반식(Ⅰ)의 화합물및/또는 이의 생리학적으로 허용되는 염의 하나를 적어도 하나의 고체, 액체 또는 반액체 부형제 또는 보조제와 함께 투여에 적합한 형태로 제조하는 것을 특징으로 하는 약학적 제제의 제조방법.
  5. 적어도 하나의 일반식(Ⅰ)의 화합물 및/또는 이의 생리학적으로 허용되는 염의 하나를 함유하는 약학적 제제.
  6. 약품의 제조를 위한 일반식(Ⅰ) 화합물의 용도.
  7. 질병을 치료하는데 있어서, 일반식(Ⅰ)의 화합물의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900011156A 1989-07-24 1990-07-23 크로만 유도체 KR910002845A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3924417.2 1989-07-24
DE3924417A DE3924417A1 (de) 1989-07-24 1989-07-24 Chromanderivate

Publications (1)

Publication Number Publication Date
KR910002845A true KR910002845A (ko) 1991-02-26

Family

ID=6385695

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900011156A KR910002845A (ko) 1989-07-24 1990-07-23 크로만 유도체

Country Status (20)

Country Link
US (1) US5143924A (ko)
EP (1) EP0410208B1 (ko)
JP (1) JPH0358983A (ko)
KR (1) KR910002845A (ko)
AR (1) AR245938A1 (ko)
AT (1) ATE107640T1 (ko)
AU (1) AU623544B2 (ko)
CA (1) CA2021684A1 (ko)
DE (2) DE3924417A1 (ko)
DK (1) DK0410208T3 (ko)
ES (1) ES2055830T3 (ko)
FI (1) FI95250C (ko)
HU (1) HU206707B (ko)
IE (1) IE63917B1 (ko)
IL (1) IL95167A (ko)
NO (1) NO176100C (ko)
NZ (1) NZ234609A (ko)
PT (1) PT94792B (ko)
TW (1) TW210337B (ko)
ZA (1) ZA905773B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
US5284838A (en) * 1987-06-23 1994-02-08 Elf Sanofi Use of 2,2-dimethylchroman-3-ol derivatives in the treatment of asthma
DE3922392A1 (de) * 1989-07-07 1991-01-17 Merck Patent Gmbh Chromanderivate
TW257762B (ko) * 1991-06-14 1995-09-21 Nippon Chemicals Pharmaceutical Co Ltd
US5250547A (en) * 1991-08-29 1993-10-05 Syntex (U.S.A.) Inc. Benzopyran derivatives
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds
EP0677519A4 (en) * 1993-11-10 1996-04-03 Japan Tobacco Inc CHROMAN DERIVATIVE AND THERAPEUTIC USE THEREOF.
US5482942A (en) * 1994-06-28 1996-01-09 American Home Products Corporation (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
US5470861A (en) * 1994-08-04 1995-11-28 Hoffmann-La Roche Inc. Method of promoting hair growth
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1770171C3 (de) * 1967-04-14 1979-08-30 Beecham Group Ltd., Brentford, Mddlesex (Grossbritannien) 2,2-Dimethyl-7-alkyl-4-(4-pyridyl)-2H-chromen-5-ole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate
US3973023A (en) * 1972-01-26 1976-08-03 Beecham Group Limited Anti-hypertensive polycyclic compounds for treating hypertension
GB1417745A (en) * 1973-07-07 1975-12-17 Beecham Group Ltd Chromene compounds
US3947462A (en) * 1974-05-22 1976-03-30 Abbott Laboratories 2,4,7-substituted 5-hydroxy benzopyrans and esters
DE2745305A1 (de) * 1977-10-07 1979-04-19 Bayer Ag Insektizide und akarizide mittel
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds
ATE56007T1 (de) * 1984-06-22 1990-09-15 Beecham Group Plc Wirksame benzopyranverbindungen.
GB8521857D0 (en) * 1985-09-03 1985-10-09 Beecham Group Plc Active compounds
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
CH674984A5 (ko) * 1987-05-16 1990-08-15 Sandoz Ag
FI90343C (fi) * 1987-06-23 1994-01-25 Merck Patent Gmbh Menetelmä korkeaa verenpainetta alentavien ja rytmihäiriöitä vastustavien trans-2,2-dimetyylikroman-3-olijohdannaisten valmistamiseksi
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
JPH0753725B2 (ja) * 1987-10-08 1995-06-07 富山化学工業株式会社 ４ｈ―１―ベンゾピラン―４―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
FR2621587B1 (fr) * 1987-10-12 1990-02-09 Sanofi Sa Derives du dimethyl-2,2 chromene, procede pour leur preparation et composition pharmaceutiques les contenant
DE3811017A1 (de) * 1988-03-31 1989-10-19 Hoechst Ag Ungesaettigte n-benzopyranyllactame
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate

Also Published As

Publication number Publication date
ZA905773B (en) 1991-05-29
HUT59130A (en) 1992-04-28
DE59006189D1 (de) 1994-07-28
JPH0358983A (ja) 1991-03-14
AU5975190A (en) 1991-01-24
FI903704A0 (fi) 1990-07-23
IL95167A (en) 1995-11-27
EP0410208B1 (de) 1994-06-22
FI95250C (fi) 1996-01-10
HU206707B (en) 1992-12-28
ATE107640T1 (de) 1994-07-15
ES2055830T3 (es) 1994-09-01
CA2021684A1 (en) 1991-01-25
IL95167A0 (en) 1991-06-10
NO176100C (no) 1995-02-01
AU623544B2 (en) 1992-05-14
IE63917B1 (en) 1995-06-14
PT94792B (pt) 1997-03-31
US5143924A (en) 1992-09-01
DE3924417A1 (de) 1991-01-31
PT94792A (pt) 1991-03-20
NZ234609A (en) 1991-04-26
TW210337B (ko) 1993-08-01
FI95250B (fi) 1995-09-29
DK0410208T3 (da) 1994-07-25
NO176100B (no) 1994-10-24
NO903275L (no) 1991-01-25
AR245938A1 (es) 1994-03-30
IE902676A1 (en) 1991-02-27
NO903275D0 (no) 1990-07-23
EP0410208A1 (de) 1991-01-30
HU904594D0 (en) 1990-12-28

Similar Documents

Publication Publication Date Title
KR880007507A (ko) 크로만 유도체
KR910002845A (ko) 크로만 유도체
PT79834B (fr) Procede de preparation de nouveaux derives de la xanthine
PT77018B (fr) Procede de preparation de nouveaux derives de la thieno (3,2-c) pyridine et de compositions pharmaceutiques les contenant
HUT52764A (en) Process for producing pyrimidindione derivatives and pharmaceutical compositions containing them as active components
KR840007596A (ko) 유기인 유도체의염의 제조방법
KR910000713A (ko) 크로만 유도체
KR910004602A (ko) 크로만 유도체
KR910000711A (ko) 크로만 유도체
KR900007798A (ko) 테트랄린 유도체
KR900006326A (ko) 크로만 유도체
DE3570437D1 (en) 1-hydroxy-1,1-diphosphonic-acid derivatives, process for their preparation and pharmaceutical preparations, especially for the treatment of bone tumours
KR910002842A (ko) 크로만 유도체
DE69821815T2 (de) Thiocolchicin-Derivate mit entzündungshemmender und muskelrelaxierender Wirkung
KR940003953A (ko) 1. 4-벤조디옥산 유도체
KR880701235A (ko) 디벤즈[b,e] 옥세핀유도체 및 그것을 유효성분으로 하는 의약
PT76196B (fr) Procede de preparation de derives d'imidazolidine et de compositions pharmaceutiques les contenant
KR910021400A (ko) 옥사졸리디논
PT89757A (pt) Processo para a preparacao de novos derivados da xantina e de composicoes farmaceuticas que os contem, uteis no tratamento da ulcera peptica
HUT46329A (en) Process for producing substituted amino-methane-diphosphonic acid derivatives
KR930004317A (ko) N-치환된 아미노메탄디포스폰산
KR880013562A (ko) 7-티아프로스타글란딘e₁ 또는 그의 유도체를 함유하는 당뇨병치료 조성물
KR900007835A (ko) 벤즈옥사진 유도체
KR890005113A (ko) 아자크로만 유도체
KR910007907A (ko) 크로만 유도체

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application